Analystreport

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at Barclays PLC from $83.00 to $92.00. They now have an "overweight" rating on

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report